Table 3.
Totals 38 |
All N (%) |
Cases 22 (%) |
Controls 16 (%) |
p | |
---|---|---|---|---|---|
CD4 % | 17 | 6 | 11 | ||
Mean (SD) | 20 (12) | 17 (13) | 22 (12) | 0·47 | |
CD4% classification | 17 | ||||
Mild Immunosuppressed (>=20%) | 7 (18·4) | 1(4·6) | 6 (37·5) | 0·16 | |
Advanced Immunosuppressed (<20%) | 10 (26·3) | 5 (22·7) | 5 (31·3) | ||
Duration of clinic attendance | 38 | ||||
# with CD4% measures | 17 | 6 | 11 | ||
Duration in days (SD) | 518 (480) | 13 (18) | 794 (363) | <0·01 | |
# without CD4% measures | 21 | 16 | 5 | ||
Duration in days (SD) | 283 (555) | 1 (0·00) | 1186 (454) | <0·01 | |
WHO staging | 31 | ||||
I | 18 (58·1) | 10 (66·7) | 8 (50·0) | 0·44 | |
II | 1(3·2) | 1 (6·7) | 0 (0·0) | ||
III | 5(16·1) | 1 (6·7) | 4 25·0) | ||
IV | 7 (22·6) | 3 (20·0) | 4 (25·0) | ||
Patient on ART | 38 | ||||
Yes | 18 (47·4) | 2 (9·1) | 16 (100·0) | <0·01 | |
No | 20 (52·6) | 20 (90·9) | 0 (0·0) | ||
Length of enrollment | 38 | 22 | 16 | ||
Mean days (SD) | 388·2 (529·6) | 4·1 (10·2) | 916·3 (421·8) | <0·01 | |
# of clinic visits | 38 | ||||
1 visit | 20 (52·6) | 20 (90·9) | 0 (0·0) | <0·01 | |
< 6 months | 2 (5·3) | 2 (9·1) | 0 (0·0) | ||
> 6 months | 16 (42·1) | 0 (0·0) | 16 (100·0) |